Team:ITESM-Guadalajara/Property
From 2014.igem.org
(Difference between revisions)
Line 386: | Line 386: | ||
<h2>INTELLECTUAL PROPERTY</h2> | <h2>INTELLECTUAL PROPERTY</h2> | ||
- | <p> | + | </br><p> |
Given the high-end technology and innovation Biophrame is creating, IP protection is needed. | Given the high-end technology and innovation Biophrame is creating, IP protection is needed. | ||
</p> | </p> | ||
Line 393: | Line 393: | ||
<p>The technology that we developed consists in: | <p>The technology that we developed consists in: | ||
</p><p> | </p><p> | ||
- | The design of a genetically modified E. coli, that in our process is the responsible of the chitin deacetylation process. | + | <ul><li>The design of a genetically modified E. coli, that in our process is the responsible of the chitin deacetylation process. |
+ | </li></ul> | ||
+ | </p><p> | ||
We are currently patenting our first invention: the design of the genetically modified E. coli able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of BioPhrame Technologies as moral person (once it is legally established). | We are currently patenting our first invention: the design of the genetically modified E. coli able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of BioPhrame Technologies as moral person (once it is legally established). | ||
</p><p> | </p><p> |
Revision as of 04:28, 16 October 2014